|
|
Volumn 343, Issue 13, 2000, Pages 972-973
|
|
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma [6]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
DEXAMETHASONE;
FAS ANTIGEN;
FAS LIGAND;
THALIDOMIDE;
ADULT;
CASE REPORT;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DOSE RESPONSE;
DRUG CROSS REACTIVITY;
DRUG SAFETY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
MALE;
MYELOMA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN BIOPSY;
TOXIC EPIDERMAL NECROLYSIS;
CASE REPORT;
DEXAMETHASONE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
EPIDERMAL NECROLYSIS, TOXIC;
GLUCOCORTICOIDS, SYNTHETIC;
HUMAN;
MALE;
MIDDLE AGE;
MULTIPLE MYELOMA;
THALIDOMIDE;
|
|
EID: 0034727058
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200009283431315 Document Type: Letter |
|
Times cited : (84)
|
|
References (0)
|
